Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899140-07-000945
Filing Date
2007-05-11
Accepted
2007-05-11 11:25:53
Documents
2
Period of Report
2007-05-08

Document Format Files

Seq Description Document Type Size
1 tpllc_nabi4-051107ex.html 4  
1 tpllc_nabi4-051107ex.xml 4 11512
2 EXHIBIT 99.1 JOINT FILER INFORMATION n3741011.txt EX-99 3745
  Complete submission text file 0000899140-07-000945.txt   17949
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Issuer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 390 PARK AVENUE NEW YORK NY 10022
Business Address 390 PARK AVENUE NEW YORK NY 10022 2122247400
Third Point LLC (Reporting) CIK: 0001040273 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-04829 | Film No.: 07840708

Mailing Address THIRD POINT MANAGEMENT COMPANY L.L.C. 360 MADISON AVENUE, 24TH FLOOR NEW YORK NY 10017
Business Address (212) 224-7400
Loeb Daniel S (Reporting) CIK: 0001300345 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-04829 | Film No.: 07840709